(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

PROTEÍNAS DE LIGAÇÃO AO ANTÍGENO QUE SE LIGAM A PD-L1

ArquivadaInvention PatentPCT · US2017015429

Application data

Number

112018015480

Type

Invention Patent

Filing

01/27/2017

Publication

05/21/2019

PCT

US2017015429

Progress at the INPI

  1. Filing01/27/17
  2. Publication05/21/19
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/28/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SORRENTO THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

H. Z. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/288,912 · 01/29/2016

Abstract

Trata-se de anticorpos de classe IgG anti-PD-L1 que têm capacidade aprimorada para serem fabricados com maiores rendimentos. De modo mais específico, revelam-se anticorpos humanos que se ligam a PD-L1, fragmentos de ligação a PD-L1 que podem ser fabricados com maiores rendimentos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

03/28/2023

RPI 2725

Parecer de pré-exame

#6.23

12/20/2022

RPI 2711

Adição na publicação

#15.35

09/21/2021

RPI 2646

Notificação de entrada na fase nacional - PCT

#1.3

05/21/2019

RPI 2524

Alteração de dados cadastrais

#1.1

04/09/2019

RPI 2518

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.